Teleflex announces CE mark for the Arrow GPSCath balloon dilatation catheter


Teleflex has announced that its subsidiary Hotspur Technologies, which Teleflex acquired in June 2012, completed CE marking requirements to market the company’s Arrow GPSCath Balloon Dilatation Catheters to the European Union. These novel products enable multiple vascular procedures to be performed with one dual-function catheter, potentially reducing procedure time and expense for both patients and medical professionals.

The Arrow GPSCath Catheter is designed as a two-in-one device that incorporates the proprietary VisioValve Injection System. This innovative combination enables physicians to perform high-pressure angioplasty and inject physician-specified fluids, such as contrast, all while maintaining the guidewire position.

“We are committed to enabling medical professionals to perform peripheral access procedures with devices that both simplify and improve the doctors’ and patients’ experiences,” said Benson Smith, chairman, president and CEO of Teleflex.